Hostname: page-component-848d4c4894-wg55d Total loading time: 0 Render date: 2024-06-01T07:49:12.977Z Has data issue: false hasContentIssue false
  • English
  • Français

Psychiatric symptoms typical of patients with dementia with Lewy bodies – similarity to those of levodopa-induced psychosis

Published online by Cambridge University Press:  24 June 2014

Eizo Iseki ,
Wami Marui ,
Namiko Nihashi  and
Kenji Kosaka
Eizo Iseki*
Affiliation:
Department of Psychiatry, Yokohama City University School of Medicine, Yokohama Japan
Wami Marui
Affiliation:
Department of Psychiatry, Yokohama City University School of Medicine, Yokohama Japan
Namiko Nihashi
Affiliation:
Department of Psychiatry, Yokohama City University School of Medicine, Yokohama Japan
Kenji Kosaka
Affiliation:
Department of Psychiatry, Yokohama City University School of Medicine, Yokohama Japan
*
Eizo Iseki MD PhD, Department of Psychiatry, Yokohama City University School of Medicine, 3–9 Fukuura, Kanazawa-ku, Yokohama 236–0004, Japan. Tel: +81-45-787-2667; Fax: +81-45-783-2540; E-mail: iseki@med.yokohama-cu.ac.jp
Get access Rights & Permissions [Opens in a new window]

Abstract

We examined psychiatric symptoms in eight cases with dementia with Lewy bodies (DLB), which included visual hallucination of persons or small animals, visual illusion, metamorphosia, leibhaftige Bewusstheit, personal or topographical misidentification, Capgras' syndrome and reduplicative paramnesia as well as depressive state and delusion of persecution. These psychiatric symptoms are identical to those of levodopa-induced psychosis, although these symptoms appeared before medication with anti-Parkinson drugs. The hypersensitivity of the dopamine receptor in the meso-limbic dopaminergic system has been presumed in levodopa-induced psychosis. We previously showed disturbance of the nigro-amygdaloid dopaminergic connections in DLB brains on pathological studies. Hypoperfusion or glucose hypometabolism in the occipital lobe has been demonstrated in DLB patients using SPECT or PET. The amygdala has reciprocal connections with the visual cortex in the occipital lobe. From these findings, it is supposed that the disturbance of the nigro-amygdaloid connections induces hypersensitivity of the dopamine receptor in the amygdala, causing psychiatric symptoms with dysfunction of the visuo-amygdaloid connections.

Keywords

dementia with Lewy bodieslevodopa-induced psychosismeso-limbic dopaminergic systempsychiatric symptomsvisual misidentification
Type
Original Article
Information
Acta Neuropsychiatrica , Volume 14 , Issue 5 , October 2002 , pp. 237 - 241
Copyright
Copyright © Acta Neuropsychiatrica 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Byrne, E, Lennox, G, Lowe, J, Godwin-Austen, RB. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989;52: 709–717.CrossRefGoogle ScholarPubMed
McKeith, IG, Galasko, D, Kosaka, Ket al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47: 1113–1124.CrossRefGoogle Scholar
Iseki, E, Marui, W, Kosaka, Ket al. Clinicopathological multiplicity of dementia with Lewy bodies. Neuropathology 1999;19: 386–394. CrossRefGoogle Scholar
McKeith, IG, Perry, RH, Fairbairn, AFet al. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992;22: 911–922.CrossRefGoogle Scholar
Klatka, LA, Louis, ED, Schiffer, RB. Psychiatric features in diffuse Lewy body disease. a clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups. Neurology 1996;47: 1148–1152.CrossRefGoogle ScholarPubMed
Goodwin, FK. Psychiatric side effects of levodopa in man. J Am Med Assoc 1971;218: 1915–1920. CrossRefGoogle ScholarPubMed
Klawans, HL. Levodopa-induced psychosis. Psychiatr Ann 1978;8: 447–451. Google Scholar
Moskovitz, C, Moses, H, Klawans, HL. Levodopa-induced psychosis: a kindling phenomenon. Am J Psychiatry 1978;135: 669–675.Google Scholar
Fisher, P, Danielczyk, W, Simanyi, M, Streifler, MB. Dopaminergic psychosis in advances Parkinson's disease. In: Streifler, MB, Korczyn, AD, Melamed, E, Youdim, MBH, eds. Advances in Neurology, Parkinson's Disease;Anatomy, Pathology, and Therapy. New York: Raven Press, 1990: 391–397. Google Scholar
Cummings, JL. Behavioral complications of drug treatment of Parkinson's disease. J Am Geriatr Soc 1991;33: 708–716. CrossRefGoogle Scholar
Peyser, CE, Naimark, D, Zuniga, R. Psychoses in Parkinson's disease patients. Semin Clin Neuropsychiatry 1998;3: 41–50.Google Scholar
Randot, P, de Recondo, J, Cognet, A, Ziegler, M. Mental disorders in Parkinson's disease after treatment with l-dopa. In: Haasler, RG, Christ, JF, eds. Advances in Neurology, Parkinson-Specific Motor and Mental Disorders. New York: Raven Press, 1984: 259–269. Google Scholar
Horiguchi, J, Inami, K, Kakimoto, Y. The psychotic symptoms, mainly hallucinations, and its drug treatment in Parkinson's disease. Jap J Clin Psychistry 1985;14: 1091–1098. Google Scholar
Lipper, S. Psychosis in patients on bromocriptine and levodopa with carbidopa. Lancet 1976: ii; 571–572. CrossRefGoogle Scholar
Cummings, JL. Depression and Parkinson's disease: a reviw. Am J Psychiatry 1992;149: 443–454.Google Scholar
Joseph, AB. Focal central nervous system abnormalities in patients with misidentification syndromes. In: Christodoulou, GN, ed. The Delusional Misidentification Syndromes. Basel: Karger, 1986: 68–79. Google Scholar
Marsh, L. Neuropsychiatric aspects of Parkinson's disease. Psychosomatics 2000;41: 15–23.CrossRefGoogle ScholarPubMed
Klawans, HL, Goetz, CG, Nausieda, PA, Weiner, WJ. Levodopa-induced dopamine receptor hypersensitivity. Ann Neurol 1977;2: 125–129. CrossRefGoogle Scholar
Javoy-Agid, F, Ruberg, M, Taquet, Het al. Biochemical neuropathology of Parkinson's disease. In: Haasler, RG, Christ, JF, eds. Advances in Neurology, Parkinson-Specific Motor and Mental Disorders. New York: Raven Press, 1984: 189–198. Google Scholar
Iseki, E, Kato, M, Marui, Wet al. A neuropathological study of the disturbance of the nigro-amygdaloid connections in brains from patients with dementia with Lewy bodies. J Neurol Sci 2001;185: 129–134.CrossRefGoogle ScholarPubMed
Albin, RL, Minoshima, S, Damato, CJet al. Fluorodeoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology 1996;47: 462–466.CrossRefGoogle ScholarPubMed
Ishii, K, Imamura, T, Sasaki, Met al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology 1998;51: 125–130.CrossRefGoogle ScholarPubMed
Ishii, K, Yamaji, S, Kitagaki, Het al. Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology 1999;53: 413–416.CrossRefGoogle ScholarPubMed
Howard, R, David, A, Woodruff, Pet al. Seeing visual hallucinations with functional magnetic resonance imaging. Dement Geriatr Cogn Disord 1997;8: 73–77.CrossRefGoogle ScholarPubMed
Imamura, T, Ishii, K, Hirono, Net al. Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB). Neuroreport 1999;10: 1903–1907.CrossRefGoogle Scholar
Teunisse, RJ, Cruysberg, JR, Hoefnagels, WHet al. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet 1996;347: 794–797.CrossRefGoogle ScholarPubMed
Parent, A. Amygdala. Carpenter's Human Neuroanatomy, 9th edn. Baltimore: Williams & Wilkins, 1996: 773–780. Google Scholar